A critical breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant suppressor protein is frequently disabled in many kinds of cancer, leading https://socials360.com/story12630488/vhh-fragments-revive-the-p53-protein-new-new-pathway-for-cancer-treatment